Partner Content Partner Content 3D Cell Culture 2018: Exclusive New Interviews Released 3D Cell Culture Interviews Released
Partner Content Partner Content Agenda Released for 3D Cell Culture 2018 Agenda Released for 3D Cell Culture 2018
News Enhertu poised to move first line in HER2+ breast cancer New data could make HER2-directed antibody-drug conjugate (ADC) Enhertu an option for previously untreated breast cancer for the first time.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
